Eisai and Merck & Co., Inc., Kenilworth, N.J., U.S.A. Announce U.S. FDA Grants Breakthrough Therapy Designation for LENVIMA
Go back to Eisai and Merck & Co., Inc., Kenilworth, N.J., U.S.A. Announce U.S. FDA Grants Breakthrough Therapy Designation for LENVIMA| Eisai Co Ltd (AMEX: ESALF) | Delayed: 28.71 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.71 | 52 Week High | $66.25 | |||
| Open | $28.71 | 52 Week Low | $53.50 | |||
| Day High | $28.71 | P/E | N/A | |||
| Day Low | $28.71 | EPS | $0.00 | |||
| Volume | 10,600 | |||||
| Eisai Co Ltd American Depositary Shares (AMEX: ESALY) | Delayed: 61.51 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $61.51 | 52 Week High | $67.60 | |||
| Open | $49.73 | 52 Week Low | $53.55 | |||
| Day High | $61.51 | P/E | N/A | |||
| Day Low | $61.51 | EPS | $0.00 | |||
| Volume | 1,907,007 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 133.49 +3.07 (2.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $130.42 | 52 Week High | $65.46 | |||
| Open | $130.25 | 52 Week Low | $47.97 | |||
| Day High | $133.53 | P/E | 90.81 | |||
| Day Low | $128.91 | EPS | $1.47 | |||
| Volume | 4,325,140 | |||||

